Resultados de la búsqueda 271-280 of 15786 for Digoxin toxicity

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The objective of this study is to utilize ultra-high-field MR neuroimaging to elucidate the structural and functional anatomy of the human nucleus accumbens ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

  6. Psiquiatría y psicología - Ensayos clínicos

    There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary endpoint is EFS and 774 eligible and evaluable patients are anticipated to enroll over approximately 5 years. Key secondary endpoints are toxicity, ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...